Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
Status:
Withdrawn
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The proposed study is a double-blind, placebo controlled pilot study of HD, PD, and DLB
subjects with sleep disturbances. This study is designed to determine the effects of 4 weeks
Ramelteon treatment on the sleep patterns of people with basal ganglia disorders such as HD,
PD and DLB. The study also aims to look at the sleep patterns of caregivers of people with
HD, PD and DLB.